146 related articles for article (PubMed ID: 32924431)
1. Modular Hepatitis B Virus-like Particle Platform for Biosensing and Drug Delivery.
Hartzell EJ; Lieser RM; Sullivan MO; Chen W
ACS Nano; 2020 Oct; 14(10):12642-12651. PubMed ID: 32924431
[TBL] [Abstract][Full Text] [Related]
2. Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization.
Brune KD; Leneghan DB; Brian IJ; Ishizuka AS; Bachmann MF; Draper SJ; Biswas S; Howarth M
Sci Rep; 2016 Jan; 6():19234. PubMed ID: 26781591
[TBL] [Abstract][Full Text] [Related]
3. Highly modular hepatitis B virus-like nanocarriers for therapeutic protein encapsulation and targeted delivery to triple negative breast cancer cells.
Yur D; Sullivan MO; Chen W
J Mater Chem B; 2023 May; 11(18):3985-3993. PubMed ID: 37083736
[TBL] [Abstract][Full Text] [Related]
4. Engineering Hepatitis B Virus (HBV) Protein Particles for Therapeutic Delivery.
Sullivan MO; Chen W
Methods Mol Biol; 2024; 2720():115-126. PubMed ID: 37775661
[TBL] [Abstract][Full Text] [Related]
5. Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.
Hyakumura M; Walsh R; Thaysen-Andersen M; Kingston NJ; La M; Lu L; Lovrecz G; Packer NH; Locarnini S; Netter HJ
J Virol; 2015 Nov; 89(22):11312-22. PubMed ID: 26339047
[TBL] [Abstract][Full Text] [Related]
6. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
[TBL] [Abstract][Full Text] [Related]
7. Covalent protein display on Hepatitis B core-like particles in plants through the in vivo use of the SpyTag/SpyCatcher system.
Peyret H; Ponndorf D; Meshcheriakova Y; Richardson J; Lomonossoff GP
Sci Rep; 2020 Oct; 10(1):17095. PubMed ID: 33051543
[TBL] [Abstract][Full Text] [Related]
8. Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity.
Joe CCD; Chatterjee S; Lovrecz G; Adams TE; Thaysen-Andersen M; Walsh R; Locarnini SA; Smooker P; Netter HJ
Vaccine; 2020 May; 38(22):3892-3901. PubMed ID: 32284273
[TBL] [Abstract][Full Text] [Related]
9. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF
Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348
[TBL] [Abstract][Full Text] [Related]
10. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
[TBL] [Abstract][Full Text] [Related]
12. Bacterial superglue enables easy development of efficient virus-like particle based vaccines.
Thrane S; Janitzek CM; Matondo S; Resende M; Gustavsson T; de Jongh WA; Clemmensen S; Roeffen W; van de Vegte-Bolmer M; van Gemert GJ; Sauerwein R; Schiller JT; Nielsen MA; Theander TG; Salanti A; Sander AF
J Nanobiotechnology; 2016 Apr; 14():30. PubMed ID: 27117585
[TBL] [Abstract][Full Text] [Related]
13. Improvement of Modular Protein Display Efficiency in SpyTag-Implemented Norovirus-like Particles.
Boonyakida J; Khoris IM; Nasrin F; Park EY
Biomacromolecules; 2023 Jan; 24(1):308-318. PubMed ID: 36475654
[TBL] [Abstract][Full Text] [Related]
14. Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide.
Schumacher J; Bacic T; Staritzbichler R; Daneschdar M; Klamp T; Arnold P; Jägle S; Türeci Ö; Markl J; Sahin U
J Nanobiotechnology; 2018 Apr; 16(1):39. PubMed ID: 29653575
[TBL] [Abstract][Full Text] [Related]
15. Display of Streptococcus iniae α-Enolase on the Surface of Virus-Like Particles (VLPs) of Nervous Necrosis Virus (NNV) Using SpyTag/SpyCatcher.
Yang JI; Kim KH
Mar Biotechnol (NY); 2022 Dec; 24(6):1066-1072. PubMed ID: 36171522
[TBL] [Abstract][Full Text] [Related]
16. New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue.
Brune KD; Howarth M
Front Immunol; 2018; 9():1432. PubMed ID: 29997617
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
18. Chimeric Virus-Like Particles of Prawn Nodavirus Displaying Hepatitis B Virus Immunodominant Region: Biophysical Properties and Cytokine Response.
Ninyio NN; Ho KL; Yong CY; Chee HY; Hamid M; Ong HK; Mariatulqabtiah AR; Tan WS
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672018
[TBL] [Abstract][Full Text] [Related]
19. His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface display.
Koho T; Ihalainen TO; Stark M; Uusi-Kerttula H; Wieneke R; Rahikainen R; Blazevic V; Marjomäki V; Tampé R; Kulomaa MS; Hytönen VP
Eur J Pharm Biopharm; 2015 Oct; 96():22-31. PubMed ID: 26170162
[TBL] [Abstract][Full Text] [Related]
20. Engineering a Virus-like Particle to Display Peptide Insertions Using an Apparent Fitness Landscape.
Robinson SA; Hartman EC; Ikwuagwu BC; Francis MB; Tullman-Ercek D
Biomacromolecules; 2020 Oct; 21(10):4194-4204. PubMed ID: 32880435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
